Mark Soave

448 total citations
17 papers, 282 citations indexed

About

Mark Soave is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Mark Soave has authored 17 papers receiving a total of 282 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Cellular and Molecular Neuroscience and 5 papers in Physiology. Recurrent topics in Mark Soave's work include Receptor Mechanisms and Signaling (14 papers), Adenosine and Purinergic Signaling (5 papers) and Neuropeptides and Animal Physiology (5 papers). Mark Soave is often cited by papers focused on Receptor Mechanisms and Signaling (14 papers), Adenosine and Purinergic Signaling (5 papers) and Neuropeptides and Animal Physiology (5 papers). Mark Soave collaborates with scholars based in United Kingdom, Australia and Netherlands. Mark Soave's co-authors include Stephen J. Hill, Leigh A. Stoddart, Stephen J. Briddon, Jeanette Woolard, Barrie Kellam, Alastair Brown, Peter J. Scammells, Laura E. Kilpatrick, Nicholas D. Kindon and Martine J. Smit and has published in prestigious journals such as Nature Communications, The FASEB Journal and Journal of Medicinal Chemistry.

In The Last Decade

Mark Soave

16 papers receiving 277 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Soave United Kingdom 11 226 99 51 40 25 17 282
Giuseppina La Sala Italy 12 250 1.1× 36 0.4× 14 0.3× 25 0.6× 23 0.9× 15 352
Joëlle Goulding United Kingdom 8 320 1.4× 134 1.4× 35 0.7× 31 0.8× 30 1.2× 18 380
Aileen Paguio United States 5 210 0.9× 73 0.7× 64 1.3× 5 0.1× 51 2.0× 9 339
Zhenmei Xu China 7 208 0.9× 80 0.8× 41 0.8× 5 0.1× 36 1.4× 11 241
Amy Grunbeck United States 8 269 1.2× 101 1.0× 79 1.5× 5 0.1× 29 1.2× 10 332
Shane C. Wright Sweden 11 375 1.7× 164 1.7× 37 0.7× 9 0.2× 21 0.8× 15 427
G. Poncet-Montange United States 9 166 0.7× 22 0.2× 12 0.2× 18 0.5× 7 0.3× 10 204
Deepangi Pandit United States 5 132 0.6× 29 0.3× 28 0.5× 25 0.6× 8 0.3× 6 363
Changyou Guo China 8 257 1.1× 84 0.8× 78 1.5× 5 0.1× 108 4.3× 18 371
Sebastian Schneider Germany 9 297 1.3× 133 1.3× 21 0.4× 4 0.1× 12 0.5× 16 366

Countries citing papers authored by Mark Soave

Since Specialization
Citations

This map shows the geographic impact of Mark Soave's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Soave with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Soave more than expected).

Fields of papers citing papers by Mark Soave

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Soave. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Soave. The network helps show where Mark Soave may publish in the future.

Co-authorship network of co-authors of Mark Soave

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Soave. A scholar is included among the top collaborators of Mark Soave based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Soave. Mark Soave is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
2.
Musgaard, Maria, Feng Qu, Mark Soave, et al.. (2024). Ligand-induced conformational changes in the β1-adrenergic receptor revealed by hydrogen-deuterium exchange mass spectrometry. Nature Communications. 15(1). 8993–8993. 13 indexed citations
3.
Nguyen, Thi, Cameron J. Nowell, Nicholas D. Kindon, et al.. (2021). Development and Application of Subtype-Selective Fluorescent Antagonists for the Study of the Human Adenosine A1 Receptor in Living Cells. Journal of Medicinal Chemistry. 64(10). 6670–6695. 11 indexed citations
4.
Goulding, Joëlle, Mark Soave, Jeanette Woolard, et al.. (2021). Subtype selective fluorescent ligands based on ICI 118,551 to study the human β2‐adrenoceptor in CRISPR/Cas9 genome‐edited HEK293T cells at low expression levels. Pharmacology Research & Perspectives. 9(3). e00779–e00779. 7 indexed citations
5.
Liebscher, Ines, Cheng‐Chih Hsiao, André F. Maia, et al.. (2021). A guide to adhesion GPCR research. FEBS Journal. 289(24). 7610–7630. 27 indexed citations
6.
Zuidscherwoude, Malou, Deirdre M. Kavanagh, Alexandre Slater, et al.. (2021). Evidence that GPVI is Expressed as a Mixture of Monomers and Dimers, and that the D2 Domain is not Essential for GPVI Activation. Thrombosis and Haemostasis. 121(11). 1435–1447. 19 indexed citations
7.
Soave, Mark, Leigh A. Stoddart, Carl W. White, et al.. (2021). Detection of genome‐edited and endogenously expressed G protein‐coupled receptors. FEBS Journal. 288(8). 2585–2601. 12 indexed citations
8.
Soave, Mark, Raimond Heukers, Barrie Kellam, et al.. (2020). Monitoring Allosteric Interactions with CXCR4 Using NanoBiT Conjugated Nanobodies. Cell chemical biology. 27(10). 1250–1261.e5. 22 indexed citations
9.
Soave, Mark, Raimond Heukers, Barrie Kellam, et al.. (2020). Monitoring Ligand-Induced Changes in Receptor Conformation with NanoBiT Conjugated Nanobodies. SSRN Electronic Journal. 1 indexed citations
10.
Soave, Mark, Barrie Kellam, Jeanette Woolard, Stephen J. Briddon, & Stephen J. Hill. (2019). NanoBiT Complementation to Monitor Agonist-Induced Adenosine A1 Receptor Internalization. SLAS DISCOVERY. 25(2). 186–194. 28 indexed citations
11.
Soave, Mark, et al.. (2019). Probe dependence of allosteric enhancers on the binding affinity of adenosine A1‐receptor agonists at rat and human A1‐receptors measured using NanoBRET. British Journal of Pharmacology. 176(7). 864–878. 15 indexed citations
12.
Kindon, Nicholas D., Mark Soave, Leigh A. Stoddart, et al.. (2019). Subtype-Selective Fluorescent Ligands as Pharmacological Research Tools for the Human Adenosine A2A Receptor. Journal of Medicinal Chemistry. 63(5). 2656–2672. 25 indexed citations
13.
Soave, Mark, Stephen J. Briddon, Stephen J. Hill, & Leigh A. Stoddart. (2019). Fluorescent ligands: Bringing light to emerging GPCR paradigms. British Journal of Pharmacology. 177(5). 978–991. 57 indexed citations
14.
Soave, Mark, Joëlle Goulding, Róbert Márkus, Stephen J. Hill, & Leigh A. Stoddart. (2019). Application of Fluorescent Purinoceptor Antagonists for Bioluminescence Resonance Energy Transfer Assays and Fluorescent Microscopy. Methods in molecular biology. 2041. 163–181. 1 indexed citations
15.
Soave, Mark, Raimond Heukers, Martine J. Smit, Stephen J. Briddon, & Stephen J. Hill. (2019). Molecular Pharmacology of a Conformational‐Specific Extracellular Nanobody Against CXCR4. The FASEB Journal. 33(S1). 1 indexed citations
17.
Soave, Mark, Leigh A. Stoddart, Alastair Brown, Jeanette Woolard, & Stephen J. Hill. (2016). Use of a new proximity assay (NanoBRET) to investigate the ligand‐binding characteristics of three fluorescent ligands to the humanβ1‐adrenoceptor expressed in HEK‐293 cells. Pharmacology Research & Perspectives. 4(5). e00250–e00250. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026